|
Applera Corporation of Norwalk, Connecticut, at #874 on the 2007 Fortune 1000 list, was one of the largest international biotechnology companies based in the United States. It was the successor company to what was the Life Sciences Division of Perkin-Elmer Corporation. Applera was not publicly traded, but instead it consisted of two major groups which are publicly traded tracking stocks in the proteomics industrial sector. These two groups were the S&P 500 listed Applera Corp-Applied Biosystems Group of Foster City, California, and Applera Corp-Celera Genomics Group of Rockville, Maryland. In 2006, the company spun off the Celera Genomics group and changed its name from Applera to Applied Biosystems. As the former Perkin-Elmer, Applera had a history dating back to 1931. But more precisely, its history dates from 1999, when Perkin-Elmer effectively split in half, and sold off its more traditional half of the business to EG&G Inc. As part of the deal, it also sold the Perkin-Elmer name, because that most properly associated with that traditional line of products, and EG&G then became the new PerkinElmer. At that point the remaining Connecticut Life Sciences company issued its two tracking stocks, and also changed its own name to PE Corporation. The Applied Biosystems group had earlier already been renamed PE Biosystems, and it retained that name in the first incarnation of its tracking stock. In 2000, the Applied Biosystems name was restored to the group, with the new stock ticker symbol ABI, and PE Corporation became Applera, a combination of its two components' names, Appl(iedCel)era.〔(APPLERA CORP Form:8-K ) sec.gov Filing Date: 11/28/2000〕〔(APPLERA CORP Form:8-K PDF ) SECDatabase, Accession Number: 0001110538-00-000004, Filing Date: November 28, 2000〕 ==Board of directors== The Applera Corporation Directors oversaw the parent corporation along with the operations of both tracking stock groups, and consequently they had the responsibility of fairly balancing the interests of both groups of investors in each stock.〔(Directors and Officers, Board of Directors ), SECDatabase, PE Corporation Annual Report - PDF, Filing Date: September 28, 1999 〕〔(Sequencer of Genome to Change Focus ), New York Times, By ANDREW POLLACK, Published: April 22, 2002〕 *Joseph F. Abely, Jr., Director since 1984, retired Chairman and CEO of Sea-Land Corporation *Robert H. Hayes, Ph.D., Director since 1985, Philip Caldwell Professor at Harvard Business School *Richard H. Ayers, Director since 1988, retired Chairman and CEO of The Stanley Works *Jean-Luc Bélingard, Director since 1993, CEO of Pierre Fabre S.A. *Carolyn W. Slayman, Ph.D., Director since 1994, Sterling Professor and Deputy Dean of Yale University School of Medicine *Orin R. Smith, Director since 1995, Chairman and CEO of Engelhard Corporation *Tony L. White, Director since 1995, Chairman, President and CEO of Applera Corporation *Georges C. St. Laurent, Jr., Director since 1996, principal of St. Laurent Properties and former CEO of Western Bank (Oregon) *Arnold J. Levine, Ph.D., Director since 1999, President and CEO of Rockefeller University *Theodore E. Martin, Director since 1999, retired President and CEO of Barnes Group Inc. *James R. Tobin, Director since 1999, President and CEO of Boston Scientific Corporation 抄文引用元・出典: フリー百科事典『 ウィキペディア（Wikipedia）』 ■ウィキペディアで「Applera」の詳細全文を読む スポンサード リンク
|